Target intelligence / Profile preview

S-formylglutathione hydrolase (ESD)

Target
ESD
Molecular classification
Enzyme, Serine hydrolase, Alpha/beta-hydrolase fold family
01

Overview

S-formylglutathione hydrolase (Esterase D, ESD) is a serine hydrolase enzyme with an alpha/beta-hydrolase fold, primarily involved in the detoxification of formaldehyde by catalyzing the hydrolysis of S-formylglutathione to glutathione and formate. It is active toward multiple substrates, including O-acetylated sialic acids, potentially contributing to sialic acid recycling. The ESD gene is located near the RB1 gene on chromosome 13q14 and is widely used as a genetic marker for retinoblastoma and Wilson's disease. While its physiological substrate is S-formylglutathione, the enzyme shows broad substrate specificity, and its activity is essential for cellular processes related to aldehyde detoxification. There are currently no direct drugs targeting ESD, and its main clinical application is as a biomarker rather than a therapeutic target[1][2][4].

Other names
Esterase DFGHESDEsterase D/formylglutathione hydrolaseMethylumbelliferyl-acetate deacetylaseFLJ11763Testicular tissue protein Li 66
02

Mechanism of action

Not applicable for current therapeutics; no direct drugs known to target ESD. The enzyme catalyzes the hydrolysis of S-formylglutathione in formaldehyde detoxification, and acts as a serine hydrolase[2][4]

03

Biological functions

Detoxification of formaldehydeHydrolysis of S-formylglutathione to glutathione and formateLikely involvement in recycling of sialic acidsGeneral esterase activity on various substrates, including O-acetylated sialic acids[2][4]
04

Disease associations

Cancer (notably as a genetic marker for retinoblastoma, linked to the RB1 gene locus)[1][2]Wilson's disease (as a genetic marker)[2]Other (may relate more generally as a biomarker than a pathogenic driver)
05

Safety considerations

No notable direct safety concerns identified for targeting ESD. Therapeutic targeting has not been reported; primary use is in genetic diagnostics[1][2][4]
06

Interacting drugs

None specifically established as of current knowledge; ESD is more often used as a biomarker/gene marker than a direct target of existing drugs[1][2][4]
07

Biomarkers

Used as a genetic marker in the prognosis/diagnosis of retinoblastomaMarker for Wilson's disease[1][2]

Beyond the preview

Go deeper on S-formylglutathione hydrolase (ESD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-formylglutathione hydrolase (ESD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call